The PGR has a crucial role in protecting against the occurrence of ovarian cancer by clearance of p53-defective lesions through the TNF-a/RIPK1/RIPK3/MLKL pathway, inducing cell necroptosis [104]. Here, RIPK3 is linked to ovarian cancer.